Collagen Supplement Testing: What Third-Party Labs Actually Find

The global hydrolyzed collagen market crossed $1.5 billion in annual sales in 2024 and continues to grow at double-digit rates. Every major supplement retailer now carries a collagen line — often several — and the private-label production pipeline has never been busier. Speed-to-market pressure in this category is intense. And that pressure is showing up in test results.

We process a significant volume of collagen supplement samples across our Southern California laboratories, and the pattern we see consistently is brands whose labels are technically formatted correctly but whose actual collagen content doesn’t hold up under rigorous third-party analysis. This isn’t uniformly true — there are collagen manufacturers doing the work right. But the category has a quality problem, and it’s more specific and testable than most people realize.

Why Collagen Is Uniquely Difficult to Verify by Standard Testing

The fundamental challenge with collagen verification is that the most common protein quantification methods — Kjeldahl and Dumas — don’t distinguish between collagen and any other nitrogen-bearing molecule. Both methods estimate protein by measuring total nitrogen content and applying a conversion factor. Which means a product can declare “20g hydrolyzed collagen peptides per serving” while actually delivering a blend of collagen, rice protein concentrate, and gelatin-grade bovine hide waste. Standard protein testing won’t catch the difference.

The proper identity marker for collagen is hydroxyproline — a modified amino acid that occurs at meaningful concentrations almost exclusively in collagen and, to a lesser degree, elastin. Most dietary proteins contain less than 0.1% hydroxyproline. Authentic bovine hide collagen hydrolysate typically contains 12–14% hydroxyproline by dry weight. When amino acid profiling by HPLC returns a hydroxyproline value of 2–3% on a product claiming to be 100% collagen, something is off.

There’s a second, subtler issue that fewer labs catch. Even for legitimate collagen hydrolysates, applying the standard nitrogen-to-protein conversion factor of 6.25 will overstate protein content. The correct factor for pure collagen is approximately 5.55, reflecting collagen’s distinctive amino acid composition — it’s high in glycine, proline, and hydroxyproline, which are relatively nitrogen-poor per gram compared to the globular proteins that the 6.25 factor was built around. A brand that applies 6.25 to a collagen hydrolysate — which most contract manufacturers do by default — will systematically inflate reported protein content by roughly 12%. That’s not a rounding error. On a 20g serving claim, it amounts to about 2.4 grams of phantom protein per serving.

What Third-Party Testing Actually Turns Up

Pulling back to look at patterns across the collagen products we’ve analyzed:

Label weight vs. actual collagen content. Approximately one-third of collagen products we test come in measurably below their stated collagen content when analyzed via hydroxyproline-based HPLC quantification. In the more significant cases, actual collagen content is 30% or more below the label claim. The common culprit is blending with cheaper protein sources — rice protein concentrate and partially hydrolyzed gelatin byproducts are the ones we see most often — to hit a protein-by-nitrogen number at lower raw material cost without adjusting the label.

Molecular weight claims. Hydrolyzed collagen is commonly marketed in molecular weight tiers: ultra-low (under 1,000 Daltons), low (1,000–3,000 Da), and standard (3,000–10,000 Da). These size claims are tied to bioavailability marketing. Whether smaller peptides absorb meaningfully more readily is a clinical question the literature hasn’t fully settled. But what we can say empirically is that molecular weight distribution claims are nearly impossible to verify without size exclusion chromatography (SEC-HPLC), and most brands aren’t running that test. Most consumers have no way to know whether the “500 Da bioactive peptide” claim on their container reflects actual product specifications or just marketing copy.

Heavy metals in marine-sourced collagen. Fish-derived collagen — made from scales, skin, and connective tissue — tends to carry a higher heavy metal burden than bovine or porcine sources, particularly for arsenic and lead. We routinely screen marine collagen products against California Prop 65 safe harbor limits, and we see marine products fail at a meaningfully higher rate than land-animal-sourced collagen. The Prop 65 maximum allowable dose level (MADL) for inorganic arsenic is 0.2 micrograms per daily serving — a threshold that some fish-collagen products exceed, particularly those drawing raw material from certain Pacific fisheries. ICP-MS testing for lead, arsenic, cadmium, and mercury isn’t optional for marine collagen products sold in California. It’s a compliance requirement.

Microbial contamination. Collagen powders are hygroscopic — they absorb atmospheric moisture readily, especially in bulk storage or improperly heat-sealed packaging. That moisture uptake creates conditions for microbial proliferation that you simply don’t encounter as often in anhydrous vitamin or mineral formulations. We run USP <2021> total aerobic count and yeast/mold on collagen products routinely, and elevated total aerobic counts (TAC) come up more often in collagen powders than in capsule-form supplements. It traces back almost universally to inadequate packaging or bulk storage conditions at the contract manufacturer.

What 21 CFR Part 111 Actually Demands — and Where Brands Fall Short

Under FDA’s dietary supplement current Good Manufacturing Practice regulations at 21 CFR Part 111, every manufacturer must establish specifications for each incoming ingredient and verify that each lot meets those specs before it enters production. That includes identity testing for every ingredient, every lot.

The problem is that Part 111’s identity testing requirements don’t prescribe which test to use — they require that it be “appropriate.” In practice, many contract manufacturers and brands are using colorimetric total protein assays to “confirm identity” of collagen ingredients. A BCA protein assay or Bradford test can tell you approximately how much protein is present. It cannot tell you whether that protein is collagen. That is not an appropriate identity test under any reasonable reading of Part 111, and FDA Warning Letters over the past several years have increasingly cited manufacturers for using non-specific tests to satisfy identity requirements for complex ingredients.

If your identity test for incoming collagen raw material is “protein content meets specification,” you’re at meaningful compliance risk — and you’re also exposed if your supplier ever quietly substitutes a cheaper protein source. Documentation matters too. Part 111 Subpart E requires you to conduct at least one identity test on each incoming lot independently. A supplier COA isn’t sufficient on its own. Many small brands either don’t know this or are betting that FDA won’t get to them. That’s a precarious bet given how actively this category is drawing agency attention.

And if you’re selling on Amazon’s marketplace, their Supplement Verification Program increasingly demands test reports from ISO 17025 accredited laboratories. A report from a competent but non-accredited lab may not satisfy an Amazon compliance request. It’s worth confirming your testing lab’s accreditation status proactively, before a listing removal forces the question.

What a Complete Collagen Testing Panel Looks Like

For brands building a testing program from scratch, or pressure-testing an existing one, here’s what a complete collagen panel should cover:

Identity confirmation. Amino acid profiling by HPLC with hydroxyproline quantification is the core test. For marine collagen, species-specific PCR adds an important layer — it confirms fish-derived collagen and not a bovine or porcine substitute, which matters for halal, kosher, and allergen declarations. For products with molecular weight claims, SEC-HPLC for molecular weight distribution should be included.

Potency and label accuracy. Calculate collagen content from hydroxyproline data using the established collagen-specific conversion (hydroxyproline represents approximately 13.5% of collagen mass in a standard Type I/III bovine hydrolysate). Compare that derived collagen value against the label claim. If they diverge by more than 10%, there’s a formulation, math, or sourcing problem to resolve.

Heavy metals. ICP-MS at minimum for lead, arsenic, cadmium, and mercury. For California distribution, compare against both FDA action levels and Prop 65 safe harbor limits — the more stringent governs. For marine collagen specifically, consider methylmercury speciation testing in addition to total mercury.

Microbiology. USP <2021> for total aerobic count and combined yeast/mold. USP <2022> for absence of Salmonella spp. and Staphylococcus aureus. If the formula blends collagen with other animal-origin proteins (whey, egg), add Listeria monocytogenes screening.

Water activity. For finished powder products, water activity (Aw) below 0.60 is the recognized threshold for microbial stability. Above that, you’re in conditions where mold can establish itself even inside sealed packaging. This test is inexpensive, fast, and skipped far too often in collagen product development.

Most brands we work with run a full panel at product launch and whenever they change suppliers, then move to an abbreviated identity-and-potency screen on each new production lot with a complete panel every 6–12 months. That’s a defensible, documented program. Testing once and archiving the report is not — and it won’t satisfy a regulatory inspection or an Amazon compliance request two years down the road.

The brands that will hold up under increasing regulatory and marketplace scrutiny are the ones who treat testing as an ongoing quality system, not a one-time launch checkbox. For a category growing as fast as collagen, where private-label sourcing from overseas manufacturers is the norm, that distinction is increasingly the difference between staying on shelf and getting delisted.

---

Written by Nour Abochama, Vice President of Operations, Qalitex Laboratories. Learn more about our team

Talk to our team about your testing needs. Contact us

Related from our network

• FDA GMP Compliance Consulting for Supplement Manufacturers — Aurora TIC provides 21 CFR audit preparation, GMP gap assessments, and regulatory strategy for supplement and food brands navigating FDA oversight.
• Raw Material Testing and Supplier Qualification Services — Ayah Labs specializes in global raw material identity testing, COA verification, and supplier qualification programs for ingredient manufacturers and brands.